PAPER Keimpema E, Barabas K, Morozov YM, Tortoriello G, Torii M, Cameron G, Yanagawa Y, Watanabe M, Mackie K, Harkany T

Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding.

J Neurosci. 2010 Oct 20;30(42):13992-4007. PubMed: 20962221

PAPER Pinnen F, Cacciatore I, Cornacchia C, Mollica A, Sozio P, Cerasa LS, Iannitelli A, Fontana A, Nasuti C, Di Stefano A

CNS delivery of L:-dopa by a new hybrid glutathione-methionine peptidomimetic prodrug.

Amino Acids. 2012 Jan;42(1):261-9. PubMed: 21080012

PAPER Calabrese V, Cornelius C, Stella AM, Calabrese EJ

Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes.

Neurochem Res. 2010 Dec;35(12):1880-915. PubMed: 21080068

PAPER Traub R, Mitsumoto H, Rowland LP

Research advances in amyotrophic lateral sclerosis, 2009 to 2010.

Curr Neurol Neurosci Rep. 2011 Feb;11(1):67-77. PubMed: 21080240

PAPER Griffin AL, Owens CB, Peters GJ, Adelman PC, Cline KM

Spatial representations in dorsal hippocampal neurons during a tactile-visual conditional discrimination task.

Hippocampus. 2012 Feb;22(2):299-308. PubMed: 21080411

PAPER Debelouchina GT, Platt GW, Bayro MJ, Radford SE, Griffin RG

Intermolecular Alignment in β(2)-Microglobulin Amyloid Fibrils.

J Am Chem Soc. 2010 Nov 15; PubMed: 21077676

PAPER Pedersen MØ, Mikkelsen K, Behrens MA, Pedersen JS, Enghild JJ, Skrydstrup T, Malmendal A, Nielsen NC

NMR reveals two-step association of Congo Red to amyloid β in low-molecular-weight aggregates.

J Phys Chem B. 2010 Dec 9;114(48):16003-10. PubMed: 21077638

PAPER Liu Q, Kou JP, Yu BY

Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation.

Neurochem Int. 2011 Jan;58(1):119-25. PubMed: 21078355

PAPER Kirvell SL, Elliott MS, Kalaria RN, Hortobágyi T, Ballard CG, Francis PT

Vesicular glutamate transporter and cognition in stroke: a case-control autopsy study.

Neurology. 2010 Nov 16;75(20):1803-9. PubMed: 21079182

Tau, total

ANTIBODY polyclonal laboratory 92e<br />(<a href="http://www.biomedexperts.com/Profile.bme/500032/Inge_Grundke-Iqbal" target="_new">Inge Grundke-Iqbal</a>, Department of Neurochemistry, New York State Institute for Basic Resea

Debra Adkins

Macon, United States

Tau

ANTIBODY polyclonal laboratory 111e<br />(<a href="http://www.biomedexperts.com/Profile.bme/1727176/Khalid_Iqbal" target="_new">Khalid Iqbal</a>, Department of Neurochemistry, New York State Institute for Basic Research in Dev

Tau 410

ANTIBODY polyclonal laboratory 134d<br />(<a href="http://www.biomedexperts.com/Profile.bme/500032/Inge_Grundke-Iqbal" target="_new">Inge Grundke-Iqbal</a>, Department of Neurochemistry, New York State Institute for Basic Rese

Tau, truncated at Asp421 (C3)

ANTIBODY monoclonal C3 laboratory TauC3<br />(Vincent L. Cryns, Cell Death Regulation Laboratory, Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University, Chicago, IL)<br />Research <a href="http://www.ncbi.nlm.ni

London: What, No Argument? Speakers Agree on Trials for Familial AD

CONFERENCE COVERAGE 2010-11-17 Conference Coverage Part 1 of this series highlighted the main points of discussion at an 8 November 2010 meeting held at the European Medicines Agency (EMA) in London. Called “Expert meeting in familial neurodegenerative disorders. Developing medicinal p